Streetbeat News

Products Services

LVTX

MRK

LAVA Therapeutics NV (LVTX) has partnered with Merck & Co Inc (MRK) to evaluate the combination of LAVA-1207 with Merck's Keytruda in a study for metastatic castration-resistant prostate cancer. Merck will supply Keytruda for the study, which is expected to begin in the first half of 2024. LAVA-1207 has shown a favorable safety profile and preliminary anti-tumor activity. LVTX stock has surged 50% on this news.

Portfolio Pulse from Vandana Singh

January 25, 2024 | 3:11 pm

CMCSA

T

VZ

Comcast Corp (NASDAQ: CMCSA) reported Q4 FY23 revenue of $31.25 billion, a 2.3% increase Y/Y, surpassing consensus estimates. Adjusted EPS was $0.84, beating the consensus of $0.79. Broadband revenue grew by 3.7% Y/Y, but the company saw a decrease in customer relationships and net losses in broadband and video customers. Wireless lines increased by 310,000. Media revenue rose by 3.1% Y/Y, and Studios revenue by 4.3% Y/Y, with Peacock's paid subscribers up nearly 50% Y/Y. Theme Parks' revenue increased by 12.2%. Comcast announced a 6.9% dividend increase and a new $15 billion share repurchase program. CMCSA shares rose by 5.16% to $46.06.

Portfolio Pulse from Anusuya Lahiri

January 25, 2024 | 2:59 pm

DNN

Denison Mines (AMEX:DNN) and Orano Canada have announced the resumption of operations at the McClean Lake uranium mine, with mining activities set to recommence in 2025. The decision is influenced by soaring uranium prices, which recently hit a 16-year high, and is expected to provide modest near-term cash flow for Denison. BMO Capital Markets analyst Alexander Pearce maintains a Hold rating on Denison.

Portfolio Pulse from Stjepan Kalinic

January 25, 2024 | 2:58 pm

V

Visa Inc. (NYSE:V) is anticipated to report Q1 earnings of $2.34 per share, up from $2.18 the previous year, with projected revenue of $8.54 billion. The company has also launched a Web3 Loyalty Engagement Solution. Ahead of the earnings call, analysts have revised their price targets, with the most accurate analysts suggesting an increase. Visa's stock closed up 0.1% at $271.65 recently.

Portfolio Pulse from Avi Kapoor

January 25, 2024 | 2:52 pm

KSCP

Knightscope, Inc. (NASDAQ:KSCP) has deployed two new autonomous security robots (ASRs) at a large parking structure in Houston, managed by a leading commercial real estate brokerage and property management firm. The ASRs, named K1 Hemisphere and K1 Tower, are designed to deter negative activities such as break-ins, trespassing, and theft, thereby enhancing safety and potentially increasing property values. Knightscope has extensive experience in securing parking lots and structures with its ASRs.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:51 pm

AMZN

CI

CVS

TSN

UNH

Tyson Foods Inc (TSN) has chosen to partner with startup Rightway, moving away from CVS Health Corp's (CVS) Caremark for pharmacy benefits management. This move, affecting 140,000 employees, is part of Tyson's strategy to reduce drug costs and increase transparency in pricing. The industry is seeing a shift towards smaller PBMs as companies like Blue Shield of California partner with Amazon.com (AMZN), Mark Cuban’s Cost Plus Drug Company, and Abarca for similar services. Major PBMs like CVS' Caremark, Cigna Inc's (CI) Evernorth, and UnitedHealth Group's (UNH) OptumRx, which control a significant market share, are facing criticism for non-transparent practices. Tyson's decision reflects a broader industry trend towards transparency and cost reduction in pharmacy benefits management.

Portfolio Pulse from Vandana Singh

January 25, 2024 | 2:49 pm

BETS

Bit Brother Limited (BETS) has announced the delivery of all necessary equipment for its second cryptocurrency mining farm. The delivery, delayed due to extreme cold weather in Texas, includes approximately 1,400 miners and other essential equipment. The miners have been installed and tested, with the majority of other equipment assembly and testing completed. The company is now awaiting inspection by Abilene City and the issuance of a Certificate of Occupancy, anticipating the commencement of Site 2 in early February 2024.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:26 pm

PFE

Pfizer Inc (NYSE:PFE) is expected to report a Q4 2023 EPS loss of $(0.22) and revenues of $14.25 billion. The company's FY24 revenue forecast includes contributions from the Seagen acquisition, with adjusted EPS guidance lower than consensus. Pfizer's obesity drug trial showed efficacy but had high dropout rates due to side effects. Additionally, a former Pfizer employee was convicted of securities fraud. PFE shares dropped 1.69% in premarket trading.

Portfolio Pulse from Vandana Singh

January 25, 2024 | 2:26 pm

FRSX

RVSN

Rail Vision, an affiliate of Foresight Autonomous Holdings (FRSX), has received approval and certifications for its Main Line System according to EU railway standards. This achievement marks a significant milestone for Rail Vision and could potentially open up opportunities for the system's deployment across European railways, enhancing safety and efficiency.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:18 pm

IONQ

IonQ Inc (NYSE:IONQ) announced it achieved a technical milestone of 35 algorithmic qubits with its IonQ Forte system a year ahead of schedule, which is expected to enhance its quantum computing capabilities. The company's stock rose following the announcement. IonQ's systems aim to tackle quantum applications in machine learning and chemistry, and some organizations, including QuantumBasel, have already purchased the system.

Portfolio Pulse from Adam Eckert

January 25, 2024 | 2:16 pm